Integrative Medicine > Tea


Cancer Research, 66, 2500-2505, March 1, 2006. (Review Article)


Abstract

Targeting Multiple Signaling Pathways by Green Tea Polyphenol (–)-Epigallocatechin-3-Gallate

Naghma Khan, Farrukh Afaq, Mohammad Saleem, Nihal Ahmad and Hasan Mukhtar

Department of Dermatology, University of Wisconsin-Madison, Madison, Wisconsin. Requests for reprints: Hasan Mukhtar, Department of Dermatology, University of Wisconsin-Madison, 1300, University Avenue, Medical Sciences Center, B-25, Madison, WI 53706. Phone: 608-263-3927; Fax: 608-263-5223; E-mail: hmukhtar@wisc.edu. Received 10/ 7/05; revised 12/ 6/05; accepted 12/21/05.


Cell signaling pathways, responsible for maintaining a balance between cell proliferation and death, have emerged as rational targets for the management of cancer. 
Emerging data amassed from various laboratories around the world suggests that green tea, particularly its major polyphenolic constituent (–)-epigallocatechin-3-gallate (EGCG), possesses remarkable cancer chemopreventive and therapeutic potential against various cancer sites in animal tumor bioassay systems and in some human epidemiologic studies. 
EGCG has been shown to modulate multiple signal transduction pathways in a fashion that controls the unwanted proliferation of cells, thereby imparting strong cancer chemopreventive as well as therapeutic effects. 
This review discusses the modulations of important signaling events by EGCG and their implications in cancer management.

© 2006 American Association for Cancer Research
Source: http://intl-cancerres.aacrjournals.org/cgi/content/abstract/66/5/2500
HTML Full Text: http://intl-cancerres.aacrjournals.org/cgi/content/full/66/5/2500
PDF Full Text: http://intl-cancerres.aacrjournals.org/cgi/reprint/66/5/2500


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP